SPAC

Valo Health and Khosla Ventures Merge to Go Public in $2.8B SPAC Deal

What You Should Know: Valo Health, the technology company using human-centric data and artificial intelligence (AI) powered computation to transform the drug discovery and development process, and Khosla Ventures Acquisition Co. (“KVAC”) (NASDAQ: KVSA), a special purpose acquisition (SPAC), announced today that they have entered… Read More »Valo Health and Khosla Ventures Merge to Go Public in $2.8B SPAC Deal

Better Therapeutics plans to go public through SPAC merger 

  • by

Digital health startup Better Therapeutics plans to go public through a SPAC merger that would value it at $187 million. The company is currently running a pivotal study to see if its app-based program could be used as a treatment for type 2 diabetes. 

4 takeaways from 23&Me’s planned SPAC deal

  • by

Consumer DNA testing company 23andMe plans to go public through a merger with a special-purpose acquisition company started by Virgin Group. As sales of DNA testing kits wane, how will 23andMe drum up new interest for its business?

Augmedix goes public through reverse merger

  • by

The company, which offers a remote scribe services, secured $25 million in private placement financing and began trading publicly on the OTC markets after a reverse merger with Malo Holdings.